FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Teresa Padró

Research Profile

Disorders

Chemicals & Drugs

Procedures

Anatomy

Physiology

Co-author Network

Publications

TOP 3
Ralf Bieker; Torsten Kessler; Christian Schwöppe; Teresa Padró; Thorsten Persigehl; Christoph Bremer; Johannes Dreischalück; Astrid Kolkmeyer; Walter Heindel; Rolf M Mesters; Wolfgang E Berdel
Infarction of tumor vessels by NGR-peptide-directed targeting of tissue factor: experimental results and first-in-man experience.
Torsten Kessler; Ralf Bieker; Teresa Padró; Christian Schwöppe; Thorsten Persigehl; Christoph Bremer; Michael Kreuter; Wolfgang E Berdel; Rolf M Mesters
Inhibition of tumor growth by RGD peptide-directed delivery of truncated tissue factor to the tumor vasculature.
Martin B Steins; Teresa Padró; Carsten Schwaenen; Sandra Ruiz; Rolf M Mesters; Wolfgang E Berdel; Joachim Kienast
Overexpression of urokinase receptor and cell surface urokinase-type plasminogen activator in the human vessel wall with different types of atherosclerotic lesions.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Teresa Padró (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2009: Ralf Bieker; Torsten Kessler; Christian Schwöppe; Teresa Padró; Thorsten Persigehl; Christoph Bremer; Johannes Dreischalück; Astrid Kolkmeyer; Walter Heindel; Rolf M Mesters; Wolfgang E Berdel
Infarction of tumor vessels by NGR-peptide-directed targeting of tissue factor: experimental results and first-in-man experience.
Blood 2009;113(20):5019-27.
2005: Torsten Kessler; Ralf Bieker; Teresa Padró; Christian Schwöppe; Thorsten Persigehl; Christoph Bremer; Michael Kreuter; Wolfgang E Berdel; Rolf M Mesters
Inhibition of tumor growth by RGD peptide-directed delivery of truncated tissue factor to the tumor vasculature.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(17):6317-24.
2004: Martin B Steins; Teresa Padró; Carsten Schwaenen; Sandra Ruiz; Rolf M Mesters; Wolfgang E Berdel; Joachim Kienast
Overexpression of urokinase receptor and cell surface urokinase-type plasminogen activator in the human vessel wall with different types of atherosclerotic lesions.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2004;15(5):383-91.
2003: Ralf Bieker; Teresa Padró; Julia Kramer; Martin B Steins; Torsten Kessler; Stephan Retzlaff; Federico Herrera; Joachim Kienast; Wolfgang E Berdel; Rolf M Mesters
Overexpression of basic fibroblast growth factor and autocrine stimulation in acute myeloid leukemia.
Cancer research 2003;63(21):7241-6.
2003: Martin B Steins; Ralf Bieker; Teresa Padró; Torsten Kessler; Joachim Kienast; Wolfgang E Berdel; Rolf M Mesters
Thalidomide for the treatment of acute myeloid leukemia.
Leukemia & lymphoma 2003;44(9):1489-93.
2003: Guido Bisping; Regine Leo; Doris Wenning; Berno Dankbar; Teresa Padró; Martin Kropff; christian scheffold; Matthias Kröger; Rolf M Mesters; Wolfgang E Berdel; Joachim Kienast
Paracrine interactions of basic fibroblast growth factor and interleukin-6 in multiple myeloma.
Blood 2003;101(7):2775-83.
2002: Teresa Padró; Ralf Bieker; Sandra Ruiz; Martin B Steins; Stephan Retzlaff; H Bürger; Thomas Büchner; Torsten Kessler; F Herrera; Joachim Kienast; Carsten Müller-Tidow; Hubert Serve; Wolfgang E Berdel; Rolf M Mesters
Overexpression of vascular endothelial growth factor (VEGF) and its cellular receptor KDR (VEGFR-2) in the bone marrow of patients with acute myeloid leukemia.
Leukemia 2002;16(7):1302-10.
2002: Stephan Retzlaff; Teresa Padró; Peter Koch; Elisabeth Oelmann; Norbert Lügering; Rolf M Mesters; Wolfgang E Berdel
Interleukin 8 and Flt3 ligand as markers of advanced disease in primary gastrointestinal non-Hodgkin's lymphoma.
Oncology reports 2002;9(3):525-7.
2002: Teresa Padró; Rolf M Mesters; Berno Dankbar; Heike Hintelmann; Ralf Bieker; Michael Kiehl; Wolfgang E Berdel; Joachim Kienast
The catalytic domain of endogenous urokinase-type plasminogen activator is required for the mitogenic activity of platelet-derived and basic fibroblast growth factors in human vascular smooth muscle cells.
Journal of cell science 2002;115(Pt 9):1961-71.
2002: Martin B Steins; Teresa Padró; Ralf Bieker; Sandra Ruiz; Martin Kropff; Joachim Kienast; Torsten Kessler; Thomas Buechner; Wolfgang E Berdel; Rolf M Mesters
Efficacy and safety of thalidomide in patients with acute myeloid leukemia.
Blood 2002;99(3):834-9.
2001: Rolf M Mesters; Teresa Padró; Martin B Steins; Ralf Bieker; Stephan Retzlaff; Torsten Kessler; Joachim Kienast; Wolfgang E Berdel
[Angiogenesis in patients with hematologic malignancies].
Onkologie 2001;24 Suppl 5():75-80.
2001: Rolf M Mesters; Teresa Padró; Ralf Bieker; Martin B Steins; Michael Kreuter; M Göner; S Kelsey; Paul Scigalla; Walter Fiedler; Thomas Büchner; Wolfgang E Berdel
Stable remission after administration of the receptor tyrosine kinase inhibitor SU5416 in a patient with refractory acute myeloid leukemia.
Blood 2001;98(1):241-3.
2000: Teresa Padró; Sandra Ruiz; Ralf Bieker; H Bürger; Martin B Steins; Joachim Kienast; Thomas Büchner; Wolfgang E Berdel; Rolf M Mesters
Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia.
Blood 2000;95(8):2637-44.
2000: Berno Dankbar; Teresa Padró; Regine Leo; B Feldmann; Martin Kropff; Rolf M Mesters; Hubert Serve; Wolfgang E Berdel; Joachim Kienast
Vascular endothelial growth factor and interleukin-6 in paracrine tumor-stromal cell interactions in multiple myeloma.
Blood 2000;95(8):2630-6.
1999: Peter Zunker; A Schick; Teresa Padró; J Kienast; A Phillips; E Bernd Ringelstein
Tissue plasminogen activator and plasminogen activator inhibitor in patients with acute ischemic stroke: relation to stroke etiology.
Neurological research 1999;21(8):727-32.
1999: Martin B Steins; Teresa Padró; CX Li; Rolf M Mesters; Helmut Ostermann; Dieter Hammel; Hans H Scheld; Wolfgang E Berdel; Joachim Kienast
Overexpression of tissue-type plasminogen activator in atherosclerotic human coronary arteries.
Atherosclerosis 1999;145(1):173-80.
1998: Joachim Kienast; Teresa Padró; Martin B Steins; CX Li; K W Schmid; Dieter Hammel; Hans H Scheld; Jürgen van de Loo
Relation of urokinase-type plasminogen activator expression to presence and severity of atherosclerotic lesions in human coronary arteries.
Thrombosis and haemostasis 1998;79(3):579-86.
1997: Teresa Padró; Martin B Steins; CX Li; Rolf M Mesters; Dieter Hammel; Hans H Scheld; Joachim Kienast
Comparative analysis of plasminogen activator inhibitor-1 expression in different types of atherosclerotic lesions in coronary arteries from human heart explants.
Cardiovascular research 1997;36(1):28-36.
1995: Teresa Padró; J J Emeis; Martin B Steins; K W Schmid; Joachim Kienast
Quantification of plasminogen activators and their inhibitors in the aortic vessel wall in relation to the presence and severity of atherosclerotic disease.
Arteriosclerosis, thrombosis, and vascular biology 1995;15(7):893-902.